Raymond James Financial
RCKT icon

Raymond James Financial’s Rocket Pharmaceuticals RCKT Stock Holding History

Raymond James Financial’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$534K Buy
149,207
+30,461
+26% +$121K ﹤0.01% 4300
2025
Q4 		$417K Sell
118,746
-11,112
-9% -$38K ﹤0.01% 4385
2025
Q3 		$423K Buy
129,858
+7,188
+6% +$22.6K ﹤0.01% 4222
2025
Q2 		$301K Buy
122,670
+91,093
+288% +$461K ﹤0.01% 4293
2025
Q1 		$211K Buy
31,577
+8,932
+39% +$88.2K ﹤0.01% 4394
2024
Q4 		$285K Buy
+22,645
New +$341K ﹤0.01% 4205

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Raymond James Financial's RCKT Position: Q1 2026 in Review

Raymond James Financial increased its Rocket Pharmaceuticals (RCKT) stake by 26% in Q1 2026, buying an estimated $121K and bringing the position to 149,207 shares worth $534K. The position accounts for ﹤0.01% of the portfolio, ranked #4300.

Raymond James Financial first reported a position in RCKT in Q4 2024 and has held it in 6 quarters since. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Raymond James Financial held 149,207 shares of Rocket Pharmaceuticals worth $534K as of Q1 2026.
  • Raymond James Financial bought 30,461 Rocket Pharmaceuticals shares in Q1 2026, an estimated $121K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4300 holding.
  • Raymond James Financial first reported a position in Rocket Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.